Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bruker AXS Inc. Files Registration Statement for Initial Public Offering.


Business Editors

MADISON, Wis.--(BUSINESS WIRE)--July 27, 2001

Bruker AXS Inc. today announced that it has filed a registration statement with the Securities and Exchange Commission for an initial public offering of shares of its common stock. All shares being offered are to be sold by the company.

The company anticipates using the net proceeds Net Proceeds

The amount received after all costs are deducted from the sale of a piece of property or security.

Notes:
In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions).
 of the offering for general corporate purposes, including research and development, expansion of sales and marketing capabilities, working capital, strategic acquisitions and repayment of outstanding debt.

UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Warburg LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 is serving as bookrunning manager with Thomas Weisel Partners Thomas Weisel Partners Group, Inc. (NASDAQ: TWPG), often shortened to just TWP or TWeisel, is a U.S. middle-market and growth focused investment banking firm based in San Francisco, California.  LLC acting as co-lead manager of the offering. CIBC World Markets CIBC World Markets is the investment banking division of the Canadian Imperial Bank of Commerce. It helps governments, large companies, and other large institutions obtain capital and credit and is a primary dealer in U.S. Treasury securities. , SG Cowen and Robert W. Baird Robert Wilson Baird (born April 1, 1883) helped found the financial services firm that bears his name and led it for more than 40 years.

Baird’s father was a professor of Greek literature at Northwestern University in Evanston, Illinois, where Baird grew up.
 & Co. are the co-managers. When available, copies of the preliminary prospectus Preliminary Prospectus

A first draft registration statement filed by a firm prior to proceeding with an initial public offering of securities. The document, filed with the Securities & Exchange Commission, is intended to provide pertinent information to prospective shareholders
 relating to this offering may be obtained from UBS Warburg LLC, 299 Park Avenue, Prospectus Department, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, NY 10171.

A registration statement relating to the securities in this offering has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time that the registration statement becomes effective. This news release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Bruker AXS is a leading worldwide developer and provider of advanced X-ray systems which provide solutions for molecular and elemental analysis by X-ray crystallography, X-ray diffraction and X-ray fluorescence. Its integrated systems, which have particular application in the drug discovery and materials science fields, provide customers with high throughout capabilities to determine the structure of specific molecules, such as proteins, and to characterize and determine the composition of materials. Bruker AXS' substantial investment in research and development allows it to design, manufacture and market technologically innovative, integrated solutions to meet the rapidly growing needs of a diverse customer base, including biotechnology and pharmaceutical companies, semiconductor companies, raw materials manufacturers, chemical companies, academic institutions and other businesses involved in materials analysis.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 27, 2001
Words:369
Previous Article:EasyLink to Review With Nasdaq Its Plan To Regain Compliance With Minimum Bid Requirement.
Next Article:FDA Advisory Committee Recommends Approval of Lilly's Forteo for the Treatment of Osteoporosis in Postmenopausal Women.



Related Articles
Bruker AXS Inc. Announces Initial Public Offering.
Bruker AXS Announces Exercise of Underwriters' Common Stock Over-Allotment Option.
Bruker AXS Reports Financial Results For the Year and the Fourth Quarter 2001.
Bruker AXS Announces Stock Repurchase Program.
Bruker AXS Inc. to Release Q3 Earnings Thursday, November 7, 2002.
Bruker AXS Inc. To Release Year-End and Fourth Quarter 2002 Earnings Thursday, February 27, 2003.
Bruker Daltonics and Bruker AXS Announce Merger Agreement.
Bruker Daltonics Announces Election Deadline in Connection with Proposed Merger with Bruker AXS.
Bruker BioSciences Announces Filing of S-3 Registration Statement.
Bruker BioSciences Announces Filing of S-3 Registration Statement.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles